Page
%P
-
Article
Open AccessTargeting Features of the Metabolic Syndrome Through Sympatholytic Effects of SGLT2 Inhibition
The moderate glucose-lowering effect of sodium glucose co-transporter 2 (SGLT2) inhibitors is unlikely to explain SGLT2 inhibitor-mediated beneficial outcomes, and unravelling the underlying mechanisms is a hi...
-
Article
New Molecules for Treating Resistant Hypertension: a Clinical Perspective
To review the findings of trials evaluating pharmacological treatment approaches for hypertension in general, and resistant hypertension (RH) in particular, and propose future research and clinical directions.